Status:
UNKNOWN
Cervical Device Contraception-2 (Nanopaz)
Lead Sponsor:
Bnai Zion Medical Center
Conditions:
Healthy
Eligibility:
FEMALE
1-2 years
Phase:
PHASE1
PHASE2
Brief Summary
Measure blood progesterone by using cervical device contraception.
Detailed Description
A very small cervical device that releases small amount of progesterone 20 mcgm/day. The target of the research is to measure blood progesterone by using the cervical device. This small device deliv...
Eligibility Criteria
Inclusion
- 10 healthy women are candidate for hysterectomy
Exclusion
- Women with neoplastic malignancy disease or thrombophylia
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00689494
Start Date
June 1 2008
End Date
May 1 2010
Last Update
June 3 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.